LI
ONC

LRI Investments’s BeOne Medicines Ltd ONC Stock Holding History

LRI Investments’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.7K Buy
20
+1
+5% +$295 ﹤0.01% 1122
2026
Q1 		$5.64K Hold
19
– – ﹤0.01% 1063
2025
Q4 		$5.77K Hold
19
– – ﹤0.01% 1016
2025
Q3 		$6.47K Hold
19
– – ﹤0.01% 978
2025
Q2 		$4.6K Hold
19
– – ﹤0.01% 1042
2025
Q1 		$5.17K Hold
19
– – ﹤0.01% 938
2024
Q4 		$3.51K Hold
19
– – ﹤0.01% 997
2024
Q3 		$3.67K Sell
19
-17
-47% -$3.06K ﹤0.01% 990
2024
Q2 		$5.14K Buy
+36
New +$5.55K ﹤0.01% 889

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LRI Investments's ONC Position: Q2 2026 in Review

LRI Investments increased its BeOne Medicines Ltd (ONC) stake by 5.3% in Q2 2026, buying an estimated $295 and bringing the position to 20 shares worth $5.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1122.

LRI Investments first reported a position in ONC in Q2 2024 and has held it in 9 quarters since. The position peaked at $6.47K in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • LRI Investments held 20 shares of BeOne Medicines Ltd worth $5.7K as of Q2 2026.
  • LRI Investments bought 1 BeOne Medicines Ltd share in Q2 2026, an estimated $295.
  • BeOne Medicines Ltd made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1122 holding.
  • LRI Investments first reported a position in BeOne Medicines Ltd in Q2 2024 and has held it in 9 quarters since.
  • LRI Investments's BeOne Medicines Ltd position peaked at $6.47K in Q3 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.